Reports Q4 revenue $355.16M, consensus $351.54M. “We finished 2024 with strong momentum by delivering better-than-expected financial results in the fourth quarter, reflecting continued strong execution,” said Fred Lampropoulos, Merit’s chairman and CEO. “Our constant currency revenue, organic, and our constant currency total revenue exceeded the high-end of our expectations in the fourth quarter. We delivered impressive year-over-year improvements in our non-GAAP operating margin and our non-GAAP earnings per share, which increased 305 basis points and 26%, respectively, year-over-year. We also delivered strong free cash flow generation in the fourth quarter and generated more than $185 million in fiscal year 2024, representing an increase of 67% year-over-year.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- MMSI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Merit Medical price target raised to $118 from $103 at BofA
- Merit Medical price target raised to $115 from $114 at Barrington
- Merit Medical price target raised to $116 from $114 at Piper Sandler
- Merit Medical price target raised to $128 from $127 at Canaccord
Questions or Comments about the article? Write to editor@tipranks.com